Marketing-authorisation holder · Greece
Gap S.A.
7 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Loading…
Marketing-authorisation holder · Greece
7 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Ligion 10 mg, zachte capsulesCapsule, zacht | Tadalafil | Netherlands | Authorised | 2019 |
| Ligion 20 mg, zachte capsulesCapsule, zacht | Tadalafil | Netherlands | Authorised | 2019 |
| Ligion 5 mg, zachte capsulesCapsule, zacht | Tadalafil | Netherlands | Authorised | 2019 |
| Xartil 10 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2023 |
| Xartil 15 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2023 |
| Xartil 20 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2023 |
| DUTASTERIDA GAP 0,5 MG CAPSULAS BLANDAS EFG0,5 mg · Cápsula blanda | Dutasteride | Spain | Withdrawn | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Gap S.A.’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callRanked by their number of medicines.